5.63
Precedente Chiudi:
$5.65
Aprire:
$5.65
Volume 24 ore:
195.29K
Relative Volume:
0.52
Capitalizzazione di mercato:
$33.05M
Reddito:
-
Utile/perdita netta:
$-26.96M
Rapporto P/E:
-0.6467
EPS:
-8.7061
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
+76.64%
1M Prestazione:
+32.48%
6M Prestazione:
-54.78%
1 anno Prestazione:
+74.19%
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Nome
Quantum Biopharma Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare QNTM vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
QNTM
Quantum Biopharma Ltd
|
5.67 | 31.30M | 0 | -26.96M | -8.25M | -8.7061 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.46 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.34 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
780.50 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
310.13 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
293.64 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Quantum Biopharma Ltd Borsa (QNTM) Ultime notizie
Quantum BioPharma Provides Corporate Update - GlobeNewswire
Top Cannabis Stocks To Follow NowApril 27th - MarketBeat
Quantum Biopharma buys additional $1 million of Bitcoin, other cryptocurrencies - MSN
QNTM Should I Buy - Intellectia AI
Quantum Biopharma bolsters Bitcoin treasury - MSN
Quantum BioPharma announces private placement - MSN
Cannabis Stocks To Watch NowApril 22nd - MarketBeat
Quantum BioPharma’s Unbuzzd Licensee Names New CEO to Drive U.S. Rollout of Clinically Backed Hangover Beverage - TipRanks
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant - The Manila Times
Unbuzzd’s new CEO to drive U.S. rollout for Quantum BioPharma (NASDAQ: QNTM) - Stock Titan
Quantum BioPharma Ltd. Announces Appointment of Richard Buzbuzian as CEO of Unbuzzd Wellness Inc. to Drive Commercialization of Innovative Beverage - Quiver Quantitative
Promising Cannabis Stocks To Follow TodayApril 21st - MarketBeat
Quantum (QNTM) Stock: Momentum Behavior Insight (Slight Rise) 2026-04-20Shared Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La
Press Releases about Royal Bank of Canada (Toronto Stock Exchange:RY) - FinancialContent
Value Recap: Should I invest in Quantum BioPharma Ltd before earnings2026 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
Operating expenses (excl. COGS) of Quantum Biopharma Ltd. Subordinate Voting Shares Class B – HAM:0K91 - TradingView — Track All Markets
Whats the fair value of Quantum BioPharma Ltd stockWeekly Gains Report & Risk Managed Investment Entry Signals - baoquankhu1.vn
Recap Report: Can Quantum BioPharma Ltd generate free cash flow2026 Historical Comparison & Stock Timing and Entry Methods - baoquankhu1.vn
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - ACCESS Newswire
Can Quantum (QNTM) Stock Beat Estimates | Price at $3.58, Down 10.05%Community Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Top Cannabis Stocks To Watch NowApril 4th - MarketBeat
QNTM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Quantum BioPharma Ltd. (QNTM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Quantum BioPharma Ltd. (QNTM) stock price, news, quote and history - Yahoo Finance UK
Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied - Sahm
Quantum Biopharma Ltd. (QNTM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cannabis Stocks To Watch TodayApril 2nd - MarketBeat
Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied - TipRanks
[6-K] Quantum Biopharma Ltd. Current Report (Foreign Issuer) | QNTM SEC FilingForm 6-K - Stock Titan
Quantum BioPharma submits IND application for MS drug candidate By Investing.com - Investing.com South Africa
Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis - Sahm
Quantum BioPharma (QNTM) Files FDA Application for New MS Drug - GuruFocus
Quantum BioPharma up 5% as Submits IND Application For Lucid-MS - marketscreener.com
Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis - TipRanks
Quantum BioPharma submits investigational new drug (IND) application to United States Food and Drug Administration (FDA) - marketscreener.com
Quantum BioPharma submits IND application for MS drug candidate - Investing.com
Quantum BioPharma (QNTM) advances Lucid-MS with FDA IND for Phase 2 MS trial - Stock Titan
BioPharma Spoofing Suit Against Canadian Banks Proceeds - Law360
Quantum Biopharma Ltd Azioni (QNTM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):